Cost-effectiveness of antiviral treatment of chronic hepatitis B in Belgium. Part 1: Literature review and results of a national study
Horsmans Y, Thiry N, le Polain M, Adler M , Colle I, Delwaide J, Michielsen P, Orlent H, Van Damme P, Hulstaert F
Record ID 32007000828
English
Details
Project Status:
Completed
Year Published:
2010
URL for published report:
https://kce.fgov.be/sites/default/files/page_documents/d20101027324.pdf
URL for additional information:
https://kce.fgov.be/publication/report/cost-effectiveness-of-antiviral-treatment-of-chronic-hepatitis-b-in-belgium-part-
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Belgium
MeSH Terms
- Antiviral Agents
- Cost-Benefit Analysis
- Hepatitis B
- Interferon-alpha
Contact
Organisation Name:
Belgian Health Care Knowledge Centre
Contact Address:
Administrative Centre Botanique, Doorbuilding (10th floor), Boulevard du Jardin Botanique 55, B-1000 Brussels, Belgium tel: +32 2 287 33 88 fax: +32 2 287 33 85
Contact Name:
info@kce.fgov.be
Contact Email:
info@kce.fgov.be
Copyright:
<p>Belgian Health Care Knowledge Centre (KCE)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.